Feasibility and Effectiveness of Virtual Reality & Use of Body Weight Support Treadmill Training in Parkinson's Disease

November 16, 2017 updated by: University Hospital of Ferrara

Feasibility and Effectiveness of Virtual Reality and the Use of Body Weight Support Treadmill Training in Parkinson's Disease: an Explorative Study

The primary hypothesis of the investigators is that a virtual reality system combined with physical activity provided on a body weight support treadmill training would change clinical parameters of balance and mobility in people with Parkinson's Disease

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ferrara, Italy, 44124
        • Recruiting
        • Ferrara University Hospital
        • Contact:
        • Principal Investigator:
          • Sofia Straudi, MD, PhD
        • Sub-Investigator:
          • Nicola Lamberti, PhD
        • Sub-Investigator:
          • Laura Di Marco Pizzongolo, PT, MSc
        • Sub-Investigator:
          • Nino Basaglia, MD
        • Sub-Investigator:
          • Carlotta Martinuzzi, PT
        • Sub-Investigator:
          • Amira Sabbagh Charabati, PT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 80 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • idiopathic Parkinson Disease diagnosis
  • age under 80 years
  • severity of disease rated 2 or 3 at Hoehn & Yahr scale

Exclusion Criteria:

  • impaired cognitive functioning: score less than 24 on the Mini Mental State Examination
  • neurologic conditions in addition to Parkinson Disease that may affect motor function and other medical conditions likely to interfere with the ability to safely complete the study protocol
  • severe Levodopa dyskinesia
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual reality
Xbox Kinect + treadmill training
12 sessions of 1 hour (30 min of virtual reality and 30 min of aerobic exercise with treadmill training): three times a week over four weeks
Active Comparator: Conventional Therapy
Specific conventional training for Parkinson's Disease
12 sessions of 1 hour of conventional physiotherapy: three times a week over four weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Six-Minute Walking Test
Time Frame: up to weeks 16
The walking endurance is measured with the Six-Minute Walking Test. Subjects are instructed to walk up and down as far as possible a 22m walkway in six minutes without encouragement, with the possibility to slow down and rest if necessary.
up to weeks 16

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg Balance Scale
Time Frame: weeks: 0,4, 16
This is an assessment scale of ability to maintain balance, or statically or while performing functional movement, including 14 observable tasks common to everyday life measured on a 5 point ordinal scale.
weeks: 0,4, 16
Time Up and Go Test
Time Frame: weeks: 0,4, 16
Subjects will be given verbal instruction to stand up from a chair, walk 3 meters, cross a line marked on the floor, turn around, walk back, and sit down. A study staff member will guard the subject during the test. Subjects will perform 3 trials and the time it takes to perform each trial will be recorded with a stopwatch.
weeks: 0,4, 16
10 meter walk test
Time Frame: weeks: 0,4, 16
Assesses walking speed in meters per second over a short duration
weeks: 0,4, 16
Unified Parkinson's Disease Rating Scale
Time Frame: weeks: 0,4, 16
It is a comprehensive assessment designed to monitor the burden and extent of Parkinson's disease across the longitudinal disease course and provide a clinical endpoint in therapy trials.
weeks: 0,4, 16
Postural sway (Center of pressure (COP) trajectories)
Time Frame: weeks: 0,4, 16
Center of pressure (COP) trajectories
weeks: 0,4, 16
Metabolic measurements by Near infrared spectroscopy
Time Frame: weeks: 0,4, 16
Near InfraRed Spectroscopy (NIRS) is a noninvasive, portable technique for ambulatory or remote monitoring of human motor-cortex oxygenation changes in response to motor tasks
weeks: 0,4, 16

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (Anticipated)

October 1, 2018

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

August 4, 2015

First Submitted That Met QC Criteria

August 5, 2015

First Posted (Estimate)

August 6, 2015

Study Record Updates

Last Update Posted (Actual)

November 20, 2017

Last Update Submitted That Met QC Criteria

November 16, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Virtual Reality

3
Subscribe